Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Sepsis

Free Subscription Articles published in Infection Retrieve available abstracts of 117 articles: HTML format

Single Articles

August 2026
1. ONORATO L, Macera M, Palamone M, Ambrisi F, et al
   Efficacy of fluoroquinolone prophylaxis in high-risk neutropenic patients with haematological malignancies: a systematic review with meta-analysis.
   Infection. 2026;54:1969-1980.
   PubMed     Abstract available
   
   
   
2. SCHAFFARCZYK L, Mayer PC, Hamprecht A, Thelen P, et al
   Clinical impact of EUCAST rapid antimicrobial susceptibility testing on empirical therapy in bloodstream infections: a real-world observational study.
   Infection. 2026;54:2001-2010.
   PubMed     Abstract available
   
   
   June 2026
3. GARROUSTE V, Jouffroy R
   Prehospital blood cultures in suspected sepsis: no need to wait until hospital arrival!
   Infection. 2026 Jun 22. doi: 10.1007/s15010-026-02866.
   PubMed    
   
   
   
4. RAHMEL T, Siegler BH, Weigand MA, Meybohm P, et al
   The evolution of sepsis care: from protocol-driven management to personalized intensive care.
   Infection. 2026 Jun 1. doi: 10.1007/s15010-026-02852.
   PubMed     Abstract available
   
   
   
5. RUHLMANN M, Xu L, Bauer M, Lehmann T, et al
   Correlation of brain injury biomarkers with brain dysfunction, brain injury, and outcomes in critically ill patients: a post hoc exploratory analysis.
   Infection. 2026;54:1501-1517.
   PubMed     Abstract available
   
   
   
6. HUANG ST, Chen PY, Huang YS, Wang JT, et al
   Clinical epidemiology, genospecies distribution, and in vitro susceptibility to novel agents among Burkholderia cepacia complex bloodstream infections in Taiwan.
   Infection. 2026;54:1289-1298.
   PubMed     Abstract available
   
   
   May 2026
7. ANDERSSON LJ, Simonsen GS, Solligard E, Fredriksen K, et al
   Evaluation of ambulance blood cultures in patients with suspected sepsis. A rural prospective cohort study.
   Infection. 2026 May 22. doi: 10.1007/s15010-026-02830.
   PubMed     Abstract available
   
   
   April 2026
8. HUBNER A, Friedrich K, Galtung N, Theobald V, et al
   From bench to triage: diagnostic utility of delta-like canonical notch ligand-1 (DLL-1) for early sepsis prediction in the emergency department.
   Infection. 2026 Apr 13. doi: 10.1007/s15010-026-02794.
   PubMed     Abstract available
   
   
   
9. BUDTZ CS, Jolving LR, Povoa P, Nielsen SL, et al
   Sex and age differences of inflammatory biomarkers around a bloodstream infection: a population-based cohort study.
   Infection. 2026;54:941-950.
   PubMed     Abstract available
   
   
   
10. HUANG W, Yang T, Ma S, Wang J, et al
    Comparative evaluation of multimodal point-of-care tests to differentiate gram-negative from gram-positive infections in critically ill adults: a diagnostic accuracy study.
    Infection. 2026;54:863-875.
    PubMed     Abstract available
    
    
    
11. BOATTINI M, Comini S, Ricciardelli G, Pastrone L, et al
    Emergence of resistance to novel beta-lactam/beta-lactamase inhibitor combinations in KPC-producing Klebsiella pneumoniae: clinical and genomic insights from consecutive bloodstream infections.
    Infection. 2026;54:841-852.
    PubMed     Abstract available
    
    
    March 2026
12. ARESKOG LEJBMAN I, Torisson G, Resman F, Sjovall F, et al
    Evaluation of the B-lactam antibiotic concentration in the early phase of treatment of patients with suspected sepsis at the emergency department.
    Infection. 2026 Mar 27. doi: 10.1007/s15010-026-02785.
    PubMed     Abstract available
    
    
    February 2026
13. CHEN CL, Chen WP, Chang FY, Yu CM, et al
    Comparison of clinical and safety outcomes in patients with Stenotrophomonas maltophilia bacteremia: a trimethoprim/sulfamethoxazole versus levofloxacin monotherapy.
    Infection. 2026;54:459-471.
    PubMed     Abstract available
    
    
    
14. RODRIGUEZ L, Grabosky LB, Cypen J
    Candida auris candidemia, septic arthritis, and vertebral osteomyelitis requiring dual antifungal therapy: a case report.
    Infection. 2026;54:527-532.
    PubMed     Abstract available
    
    
    
15. KONTULA KSK, Skogberg K, Ollgren J, Jarvinen A, et al
    Characteristics, incidence and outcome of polymicrobial bloodstream infections: a nationwide population-based study, Finland, 2004-2018.
    Infection. 2026;54:169-177.
    PubMed     Abstract available
    
    
    December 2025
16. THOMAS-RUDDEL D, Rose N, Fleischmann-Struzek C, Reinhart K, et al
    Think sepsis, write sepsis, code sepsis - patient characteristics associated with sepsis (under-)coding in administrative health data.
    Infection. 2025 Dec 8. doi: 10.1007/s15010-025-02685.
    PubMed     Abstract available
    
    
    
17. HUANG L, Liu Z, Bai Z, Zhou M, et al
    A fatal pediatric case of meningitis and streptococcal toxic shock syndrome caused by emm12 Streptococcus pyogenes strain in Jiangsu, China, 2024.
    Infection. 2025;53:2903-2907.
    PubMed     Abstract available
    
    
    
18. ALA-KOKKO TI, Karhu JM, Lehto P, Salkio S, et al
    Long-term outcomes of ICU-acquired infections with a focus on bloodstream infections: a single-center retrospective registry study.
    Infection. 2025;53:2727-2738.
    PubMed     Abstract available
    
    
    
19. MARTIN-LATORRE R, Haener K, Arrando H, Frasquet J, et al
    Blood transcriptomic for the diagnosis of nosocomial infections in critically ill patients: an observational proof-of-concept study.
    Infection. 2025;53:2613-2618.
    PubMed     Abstract available
    
    
    
20. OLIVARES-NAVARRO P, Perez-Rodriguez MT, Goikoetxea-Agirre AJ, Reguera-Iglesias JM, et al
    Development and validation of a predictive mortality scoring model for bloodstream infections due to Escherichia coli in the PROBAC cohort.
    Infection. 2025;53:2681-2689.
    PubMed     Abstract available
    
    
    
21. DICKSTEIN Y, Yahav D, Tiseo G, Mussini C, et al
    Carbapenemase type and mortality in blood-stream infections caused by carbapenemase-producing enterobacterales: a multicenter retrospective cohort study.
    Infection. 2025;53:2491-2501.
    PubMed     Abstract available
    
    
    
22. LAZZARI R, Borja Cano M, Rivera Martinez A, Rubio Bueno M, et al
    Vibrio fluvialis cholangitis with bacteremia and refractory septic shock: a case report and review of the literature.
    Infection. 2025;53:2883-2887.
    PubMed     Abstract available
    
    
    October 2025
23. JOOST FEA, Rose N, Kimmig A, Ruhnke T, et al
    Long-term outcomes after intensive care unit-treated COVID-19, influenza and respiratory sepsis in 2020 - a comparative, population-based cohort study.
    Infection. 2025 Oct 3. doi: 10.1007/s15010-025-02644.
    PubMed     Abstract available
    
    
    
24. PRAGER M, Bergmann F, Pracher L, Copic D, et al
    Antimicrobial treatment for 7 versus 14 days in patients with bacteremia: a meta-analysis of randomized controlled trials.
    Infection. 2025;53:2159-2168.
    PubMed     Abstract available
    
    
    
25. ZIMMERMANN V, Fourre N, Senn L, Guery B, et al
    Predictors of mortality of enterococcal bacteraemia and the role of source control interventions; a retrospective cohort study.
    Infection. 2025;53:2149-2158.
    PubMed     Abstract available
    
    
    
26. WEBER F, Scharf C, Aulin LBS, Weinelt F, et al
    Model-informed identification of optimised dosing strategies for meropenem in critically ill patients receiving SLEDD: an observational study.
    Infection. 2025;53:1819-1831.
    PubMed     Abstract available
    
    
    
27. MANSSON TS, Askemyr A, Sunnerhagen T, Tham J, et al
    Piperacillin/tazobactam versus carbapenems for 30-day mortality in patients with ESBL-producing Enterobacterales bloodstream infections: a retrospective, multicenter, non-inferiority, cohort study.
    Infection. 2025;53:1769-1777.
    PubMed     Abstract available
    
    
    
28. MACPHAIL A, Chraiti MN, Nguyen A, Catho G, et al
    Epidemiology of hospital-acquired bloodstream infections in haemato-oncology patients in Geneva, Switzerland.
    Infection. 2025;53:1929-1939.
    PubMed     Abstract available
    
    
    
29. TEIXEIRA-ANTUNES A, Zimmermann V, Fourre N, Ianculescu N, et al
    Factors associated with persistent bacteraemia among patients with suspected infective endocarditis.
    Infection. 2025;53:2015-2024.
    PubMed     Abstract available
    
    
    
30. WOLF S, Weber S, Janetta A, Klein F, et al
    Epidemiology and outcomes of Candida spp. bloodstream infections in cancer patients: a comparative retrospective study from a German tertiary cancer center.
    Infection. 2025;53:1875-1885.
    PubMed     Abstract available
    
    
    
31. THIPMONTREE W, Lerssuttipon U, Chunharas P, Kajeekul R, et al
    Streptococcus suis endocarditis: prognostic factors and antimicrobial resistance.
    Infection. 2025;53:1779-1787.
    PubMed     Abstract available
    
    
    
32. MEINI S, Del Cesta R, Sbrana F, Rosada J, et al
    Clinical outcomes of patients hospitalized in internal medicine wards adequately treated for bloodstream infections caused by NDM-producing Klebsiella pneumoniae. Results from a real-life retrospective multi-center study in an endemic area.
    Infection. 2025;53:1737-1744.
    PubMed     Abstract available
    
    
    
33. GEREMIA N, Giovagnorio F, Vena A, Corcione S, et al
    Risk factors for 30-Day mortality and the role of empirical therapy in Pseudomonas aeruginosa bloodstream infections.
    Infection. 2025;53:2243-2256.
    PubMed     Abstract available
    
    
    August 2025
34. BRACHT T, Weber M, Kappler K, Palmowski L, et al
    Machine learning identifies clinical sepsis phenotypes that translate to the plasma proteome.
    Infection. 2025 Aug 28. doi: 10.1007/s15010-025-02628.
    PubMed     Abstract available
    
    
    
35. SHAH S, Slaven B, Clarke LG, Ludwig J, et al
    Clinical and microbiologic outcomes of Stenotrophomonas maltophilia bloodstream infections.
    Infection. 2025;53:1483-1489.
    PubMed     Abstract available
    
    
    
36. FOURRE N, Zimmermann V, Senn L, Monney P, et al
    Comparison of the 2023 ISCVID and ESC Duke clinical criteria for the diagnosis of infective endocarditis among patients with positive blood cultures for new typical microorganisms.
    Infection. 2025;53:1393-1401.
    PubMed     Abstract available
    
    
    
37. RENGGLI L, Burri A, Ehrhard S, Gasser M, et al
    Incidence and resistance rates of Pseudomonas aeruginosa bloodstream infections in Switzerland: a nationwide surveillance study (2010-2022).
    Infection. 2025;53:1373-1381.
    PubMed     Abstract available
    
    
    
38. CAMP J, Heine V, Bayrhuber M, Anka N, et al
    Longterm efficacy of a patient focused intervention in patients with asplenia- a three year follow-up of the PrePPS trial.
    Infection. 2025;53:1449-1455.
    PubMed     Abstract available
    
    
    
39. KALBITZ S, Marx K, Kellner N, Glas A, et al
    Impact of adherence to quality indicators and effects of targeted treatment with cefazolin or flucloxacillin on in-hospital mortality in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bloodstream infections: a retrospective observa
    Infection. 2025;53:1457-1468.
    PubMed     Abstract available
    
    
    
40. FOSBOL EL, Stahl A, Roder A, Nordsten CB, et al
    Transurethral resection of the prostate (TUR-P) and associated risk of infective endocarditis.
    Infection. 2025;53:1351-1361.
    PubMed     Abstract available
    
    
    
41. KESSEL J, Bug G, Steffen B, Brunnberg U, et al
    Risk factors and outcome of Pseudomonas aeruginosa bloodstream infections (PABSI) in hematological patients: a single center retrospective cohort study.
    Infection. 2025;53:1383-1392.
    PubMed     Abstract available
    
    
    July 2025
42. JUNG C, Oetzmann N, Gillmann HJ, Stueber T, et al
    Identification and longitudinal assessment of sepsis phenotypes derived from routine clinical data in critically ill patients: a retrospective repeated measures latent profile analysis.
    Infection. 2025 Jul 23. doi: 10.1007/s15010-025-02607.
    PubMed     Abstract available
    
    
    
43. WEDEKIND L, Rose N, Freytag A, Kimmig A, et al
    Rehospitalizations for ambulatory care sensitive conditions in sepsis survivors- a nationwide cohort study using health claims data 2016-2019.
    Infection. 2025 Jul 18. doi: 10.1007/s15010-025-02606.
    PubMed     Abstract available
    
    
    
44. ALLEN VB, Bechman K, Russell MD, Adas MA, et al
    Rising rates of sepsis in England: an ecological study.
    Infection. 2025 Jul 15. doi: 10.1007/s15010-025-02601.
    PubMed     Abstract available
    
    
    
45. RUHNKE T, Storch J, Freytag A, Rose N, et al
    Transitional care after hospitalization for sepsis in Germany- results from the population-based AVENIR cohort study.
    Infection. 2025 Jul 8. doi: 10.1007/s15010-025-02589.
    PubMed     Abstract available
    
    
    June 2025
46. STEWART AG, Harris PNA, Edwards F, Kiani B, et al
    Klebsiella pneumoniae species complex bloodstream infection in adult patients: changing epidemiology and determinants of poor outcomes.
    Infection. 2025;53:1179-1187.
    PubMed     Abstract available
    
    
    
47. TISEO G, Galfo V, Carbonara S, Marino A, et al
    Bacteremic nosocomial pneumonia caused by Gram-negative bacilli: results from the nationwide ALARICO study in Italy.
    Infection. 2025;53:1041-1050.
    PubMed     Abstract available
    
    
    
48. ONORATO L, de Luca I, Salvati A, Monari C, et al
    Piperacillin/tazobactam vs. cefepime or carbapenems for the treatment of bloodstream infections due to bacteria producing chromosomal AmpC beta-lactamase: a systematic review and meta-analysis.
    Infection. 2025;53:1141-1153.
    PubMed     Abstract available
    
    
    
49. CHERNY SS, Brzezinski RY, Wasserman A, Adler A, et al
    Characterizing CRP dynamics during acute infections.
    Infection. 2025;53:1199-1203.
    PubMed     Abstract available
    
    
    May 2025
50. NEUMANN C, Leitner M, Bloos F, Lange D, et al
    Clinical value of circulating bioactive adrenomedullin for prediction of outcome and hydrocortisone response in sepsis patients-a post-hoc analysis of the HYPRESS trial.
    Infection. 2025 May 30. doi: 10.1007/s15010-025-02569.
    PubMed     Abstract available
    
    
    April 2025
51. ZHAO C, Liu P, Lin X, Wan C, et al
    The type VI secretion system as a potential predictor of subsequent bloodstream infection of carbapenem-resistant Klebsiella pneumoniae strains on intestinal colonization.
    Infection. 2025;53:667-678.
    PubMed     Abstract available
    
    
    
52. MISCHNIK A, Baltus H, Walker SV, Behnke M, et al
    Gram-negative bloodstream infections in six German university hospitals, 2016-2020: clinical and microbiological features.
    Infection. 2025;53:625-633.
    PubMed     Abstract available
    
    
    
53. WU JY, Liu MY, Liu TH, Huang PY, et al
    Effect of hydrocortisone-fludrocortisone combination on mortality in septic shock: a systematic review and meta-analysis.
    Infection. 2025;53:553-560.
    PubMed     Abstract available
    
    
    February 2025
54. G GURTLER L, Schramm W, Seitz R
    Viral sepsis - pathophysiology and disease manifestation.
    Infection. 2025 Feb 17. doi: 10.1007/s15010-025-02486.
    PubMed     Abstract available
    
    
    
55. STAROSTA AD, Ehler J, Loffler B, Tannapfel A, et al
    Echovirus serotype 11 induced sepsis in a young female patient with multiple sclerosis treated with anti-CD20 monoclonal antibody ocrelizumab.
    Infection. 2025 Feb 5. doi: 10.1007/s15010-025-02479.
    PubMed     Abstract available
    
    
    
56. JIN W, Yang D, Xu Z, Song J, et al
    Predicting the risk of invasive fungal infections in ICU sepsis population: the AMI risk assessment tool.
    Infection. 2025 Feb 3. doi: 10.1007/s15010-024-02465.
    PubMed     Abstract available
    
    
    
57. LEE CC, Ho CY, Hong MY, Hung YP, et al
    A simple scoring algorithm predicting paravertebral and/or iliopsoas abscess among adults with community-onset bloodstream infections: matters of PVL-producing Staphylococcus aureus.
    Infection. 2025;53:209-220.
    PubMed     Abstract available
    
    
    
58. LIN YC, Yang KY, Peng CK, Chan MC, et al
    Clinical outcomes of carbapenem-resistant gram-negative bacterial bloodstream infection in patients with end-stage renal disease in intensive care units: a multicenter retrospective observational study.
    Infection. 2025;53:197-207.
    PubMed     Abstract available
    
    
    
59. CASALE R, Boattini M, Comini S, Bastos P, et al
    Clinical and microbiological features of positive blood culture episodes caused by non-fermenting gram-negative bacilli other than Pseudomonas and Acinetobacter species (2020-2023).
    Infection. 2025;53:183-196.
    PubMed     Abstract available
    
    
    
60. PAPADIMITRIOU-OLIVGERIS M, Senn L, Jacot D, Guery B, et al
    Predictors of mortality of Pseudomonas aeruginosa bacteraemia and the role of infectious diseases consultation and source control; a retrospective cohort study.
    Infection. 2025;53:117-124.
    PubMed     Abstract available
    
    
    December 2024
61. MARGALIT I, Yahav D, Hoffman T, Tabah A, et al
    Presentation, management, and outcomes of older compared to younger adults with hospital-acquired bloodstream infections in the intensive care unit: a multicenter cohort study.
    Infection. 2024;52:2435-2443.
    PubMed     Abstract available
    
    
    
62. NAGAOKA K, Iwanaga N, Murai Y, Kawasuji H, et al
    Clinical phenotype of anaerobic bacteremia unaccompanied by detectable abscess lesion: a 10-year retrospective, multicenter, observational-cohort study.
    Infection. 2024;52:2415-2424.
    PubMed     Abstract available
    
    
    November 2024
63. VON DER FORST M, Back L, Tourelle KM, Gruneberg D, et al
    SeptAsTERS- SeptiCyte(R) RAPID as assessment tool for early recognition of sepsis - a prospective observational study.
    Infection. 2024 Nov 22. doi: 10.1007/s15010-024-02409.
    PubMed     Abstract available
    
    
    
64. GRASPEUNTNER S, Lupatsii M, van Zandbergen V, Dammann MT, et al
    Infants < 90 days of age with late-onset sepsis display disturbances of the microbiome-immunity interplay.
    Infection. 2024 Nov 14. doi: 10.1007/s15010-024-02396.
    PubMed     Abstract available
    
    
    October 2024
65. HORNUSS D, Gopel S, Walker SV, Tobys D, et al
    Epidemiological trends and susceptibility patterns of bloodstream infections caused by Enterococcus spp. in six German university hospitals: a prospectively evaluated multicentre cohort study from 2016 to 2020 of the R-Net study group.
    Infection. 2024;52:1995-2004.
    PubMed     Abstract available
    
    
    
66. BERGE A, Lundin J, Blackberg A, Sunnerhagen T, et al
    Non-betahemolytic streptococcal bacteremia, cardiac implantable electronic device, endocarditis, extraction, and outcome; a population-based retrospective cohort study.
    Infection. 2024;52:1911-1919.
    PubMed     Abstract available
    
    
    
67. MARANGOS M, Ioannou P, Senn L, Spiliopoulou A, et al
    Role of source control in critically ill candidemic patients: a multicenter retrospective study.
    Infection. 2024;52:1733-1743.
    PubMed     Abstract available
    
    
    
68. MONDAL U, Warren E, Bookstaver PB, Kohn J, et al
    Incidence and predictors of complications in Gram-negative bloodstream infection.
    Infection. 2024;52:1725-1731.
    PubMed     Abstract available
    
    
    September 2024
69. GENSEKE S, Berisha M, Teerstegen A, Meyer B, et al
    Lautropia mirabilis sepsis in immunodeficiency: first report and genomic features.
    Infection. 2024 Sep 6. doi: 10.1007/s15010-024-02388.
    PubMed     Abstract available
    
    
    August 2024
70. ALDEWERELD Z, Connolly B, Banks RK, Reeder R, et al
    Risk factors for prolonged infection and secondary infection in pediatric severe sepsis.
    Infection. 2024 Aug 8. doi: 10.1007/s15010-024-02355.
    PubMed     Abstract available
    
    
    
71. HUANG R, Lu TL, Liu RH
    Comparison of the accuracy of hematological parameters in the diagnosis of neonatal sepsis: a network meta-analysis.
    Infection. 2024 Aug 2. doi: 10.1007/s15010-024-02354.
    PubMed     Abstract available
    
    
    
72. FUKUSHIMA S, Hagiya H, Kuninaga N, Haruki Y, et al
    Adherence to and clinical utility of "quality indicators" for Staphylococcus aureus bacteremia: a retrospective, multicenter study.
    Infection. 2024;52:1527-1538.
    PubMed     Abstract available
    
    
    
73. TIETAVAINEN J, Seiskari T, Aittoniemi J, Huhtala H, et al
    Assessment of a novel BLOOMY score for predicting mortality in hospitalised adults with bloodstream infection.
    Infection. 2024;52:1511-1517.
    PubMed     Abstract available
    
    
    
74. FUSZL A, Schindler S, Heger F, Markowicz M, et al
    Recurrent, ICD-associated L. monocytogenes bacteraemia with multiple septic pulmonary embolisms over a 2-year period.
    Infection. 2024;52:1615-1620.
    PubMed     Abstract available
    
    
    June 2024
75. WITOWSKI A, Palmowski L, Rahmel T, Nowak H, et al
    Activation of the MAPK network provides a survival advantage during the course of COVID-19-induced sepsis: a real-world evidence analysis of a multicenter COVID-19 Sepsis Cohort.
    Infection. 2024 Jun 19. doi: 10.1007/s15010-024-02325.
    PubMed     Abstract available
    
    
    
76. ZAYET S, Gendrin V, Vuillemenot JB, Plantin J, et al
    Emergence of Campylobacter fetus bacteraemias in the last decade, France.
    Infection. 2024;52:1185-1187.
    PubMed    
    
    
    
77. ABUELAZM MT, Elzeftawy MA, Kamal MA, Badr H, et al
    Protective efficacy and safety of radiation-attenuated and chemo-attenuated Plasmodium Falciparum sporozoite vaccines against controlled and natural malaria infection: a systematic review and meta-analysis of randomized controlled trials.
    Infection. 2024;52:707-722.
    PubMed     Abstract available
    
    
    
78. SCHMIDT-HELLERAU K, Breuninger M, Kessel J, Vehreschild MJGT, et al
    Flucloxacillin and cefazolin for treatment of Staphylococcus aureus bloodstream infection.
    Infection. 2024;52:1159-1163.
    PubMed     Abstract available
    
    
    
79. LI Y, Huang K, Yin J, Tan Z, et al
    Clinical evaluation of a multiplex droplet digital PCR for pathogen detection in critically ill COVID-19 patients with bloodstream infections.
    Infection. 2024;52:1027-1039.
    PubMed     Abstract available
    
    
    
80. BAEK YJ, Song JE, Kim EJ, Choi H, et al
    Trends, clinical characteristics, antimicrobial susceptibility patterns, and outcomes of Campylobacter bacteraemia: a multicentre retrospective study.
    Infection. 2024;52:857-864.
    PubMed     Abstract available
    
    
    May 2024
81. PRINZ JC, French LE
    Generalized pustular psoriasis of the 'von Zumbusch'-type: a sepsis mimic with low PCT values.
    Infection. 2024 May 2. doi: 10.1007/s15010-024-02276.
    PubMed    
    
    
    April 2024
82. LIYANARACHI KV, Mohus RM, Rogne T, Gustad LT, et al
    Chronic kidney disease and risk of bloodstream infections and sepsis: a 17-year follow-up of the population-based Trondelag Health Study in Norway.
    Infection. 2024 Apr 29. doi: 10.1007/s15010-024-02265.
    PubMed     Abstract available
    
    
    
83. LI L, Zhou L, Peng X, Zhang Z, et al
    Association of stress hyperglycemia ratio and mortality in patients with sepsis: results from 13,199 patients.
    Infection. 2024 Apr 28. doi: 10.1007/s15010-024-02264.
    PubMed     Abstract available
    
    
    
84. BOEKHOUD L, Schaap HMEA, Huizinga RL, Olgers TJ, et al
    Correction to: Predictive performance of NEWS and qSOFA in immunocompromised sepsis patients at the emergency department.
    Infection. 2024 Apr 26. doi: 10.1007/s15010-024-02282.
    PubMed    
    
    
    
85. LIANG M, Xu Y, Ren X, Huang D, et al
    The U-shaped association between serum osmolality and 28-day mortality in patients with sepsis: a retrospective cohort study.
    Infection. 2024 Apr 22. doi: 10.1007/s15010-024-02256.
    PubMed     Abstract available
    
    
    
86. VAN STAA TP, Pate A, Martin GP, Sharma A, et al
    Sepsis and case fatality rates and associations with deprivation, ethnicity, and clinical characteristics: population-based case-control study with linked primary care and hospital data in England.
    Infection. 2024 Apr 16. doi: 10.1007/s15010-024-02235.
    PubMed     Abstract available
    
    
    
87. BOEKHOUD L, Schaap HMEA, Huizinga RL, Olgers TJ, et al
    Predictive performance of NEWS and qSOFA in immunocompromised sepsis patients at the emergency department.
    Infection. 2024 Apr 12. doi: 10.1007/s15010-024-02247.
    PubMed     Abstract available
    
    
    
88. BANZ M, Stallmach A, Gassler N, Schulze PC, et al
    Fatal pulmonary hemorrhage, pneumothorax and skin necrosis caused by IRIS to an Aspergillus flavus infection in a young patient with metamizole associated agranulocytosis.
    Infection. 2024;52:685-690.
    PubMed     Abstract available
    
    
    March 2024
89. BERNINGHAUSEN C, Schwab F, Gropmann A, Leidel BA, et al
    Deficits in blood culture collection in the emergency department if sepsis is suspected: results of a retrospective cohort study.
    Infection. 2024 Mar 5. doi: 10.1007/s15010-024-02197.
    PubMed     Abstract available
    
    
    February 2024
90. PIEDMONT S, Goldhahn L, Swart E, Robra BP, et al
    Sepsis incidence, suspicion, prediction and mortality in emergency medical services: a cohort study related to the current international sepsis guideline.
    Infection. 2024 Feb 19. doi: 10.1007/s15010-024-02181.
    PubMed     Abstract available
    
    
    
91. ROSEAU-VINCENTI A, Forestier E, Lanoix JP, Ricard C, et al
    Empirical antibiotic therapy modalities for Enterobacteriaceae bloodstream infections in older patients and their impact on mortality: a multicentre retrospective study.
    Infection. 2024;52:155-163.
    PubMed     Abstract available
    
    
    
92. PAPADIMITRIOU-OLIVGERIS M, Guery B, Ianculescu N, Auberson D, et al
    Risk of embolic events before and after antibiotic treatment initiation among patients with left-side infective endocarditis.
    Infection. 2024;52:117-128.
    PubMed     Abstract available
    
    
    
93. CHRISTNER M, Abdennadher B, Wichmann D, Kluge S, et al
    The added value of (1,3)-beta-D-glucan for the diagnosis of Invasive Candidiasis in ICU patients: a prospective cohort study.
    Infection. 2024;52:73-81.
    PubMed     Abstract available
    
    
    January 2024
94. LENGQUIST M, Varadarajan A, Alestam S, Friberg H, et al
    Sepsis mimics among presumed sepsis patients at intensive care admission: a retrospective observational study.
    Infection. 2024 Jan 27. doi: 10.1007/s15010-023-02158.
    PubMed     Abstract available
    
    
    December 2023
95. JINDAL J, Launer D, France HS, Hey M, et al
    Preventable deaths involving sepsis in England and Wales, 2013-2022: a systematic case series of coroners' reports.
    Infection. 2023 Dec 11. doi: 10.1007/s15010-023-02140.
    PubMed     Abstract available
    
    
    
96. ZUERCHER P, Moser A, Garcia de Guadiana-Romualdo L, Llewelyn MJ, et al
    Discriminative performance of pancreatic stone protein in predicting ICU mortality and infection severity in adult patients with infection: a systematic review and individual patient level meta-analysis.
    Infection. 2023;51:1797-1807.
    PubMed     Abstract available
    
    
    
97. OSTERGAARD L, Voldstedlund M, Bruun NE, Bundgaard H, et al
    Recurrence of bacteremia and infective endocarditis according to bacterial species of index endocarditis episode.
    Infection. 2023;51:1739-1747.
    PubMed     Abstract available
    
    
    
98. CAMP J, Bayrhuber M, Anka N, Heine V, et al
    Efficacy of a novel patient-focused intervention aimed at increasing adherence to guideline-based preventive measures in asplenic patients: the PrePSS trial.
    Infection. 2023;51:1787-1795.
    PubMed     Abstract available
    
    
    
99. TOBUDIC S, Bahrs C, Schneider L, Paulussen E, et al
    Early treatment response to piperacillin/tazobactam in patients with bloodstream infections caused by non-ESBL ampicillin/sulbactam-resistant Escherichia coli: a binational cohort study.
    Infection. 2023;51:1749-1758.
    PubMed     Abstract available
    
    
    
100. LARCHER R, Laffont-Lozes P, Naciri T, Bourgeois PM, et al
     Continuous infusion of meropenem-vaborbactam for a KPC-3-producing Klebsiella pneumoniae bloodstream infection in a critically ill patient with augmented renal clearance.
     Infection. 2023;51:1835-1840.
     PubMed     Abstract available
     
     
     October 2023
101. GEISMANN F, Handschuh S, Malfertheiner M, Salzberger B, et al
     Short report: impact of selective reporting of antibiotic susceptibility testing on antibiotic use in patients with bloodstream infection with Enterococcus faecalis.
     Infection. 2023;51:1557-1562.
     PubMed     Abstract available
     
     
     
102. CHAMAT-HEDEMAND S, Dahl A, Ostergaard L, Arpi M, et al
     Streptococcal species as a prognostic factor for mortality in patients with streptococcal bloodstream infections.
     Infection. 2023;51:1513-1522.
     PubMed     Abstract available
     
     
     
103. LAUPLAND KB, Edwards F, Harris PNA, Paterson DL, et al
     Significant clinical differences but not outcomes between Klebsiella aerogenes and Enterobacter cloacae bloodstream infections: a comparative cohort study.
     Infection. 2023;51:1445-1451.
     PubMed     Abstract available
     
     
     September 2023
104. SKEI NV, Nilsen TIL, Mohus RM, Prescott HC, et al
     Correction: Trends in mortality after a sepsis hospitalization: a nationwide prospective registry study from 2008 to 2021.
     Infection. 2023 Sep 21. doi: 10.1007/s15010-023-02090.
     PubMed    
     
     
     
105. SCHWARZKOPF D, Rose N, Fleischmann-Struzek C, Boden B, et al
     Understanding the biases to sepsis surveillance and quality assurance caused by inaccurate coding in administrative health data.
     Infection. 2023 Sep 9. doi: 10.1007/s15010-023-02091.
     PubMed     Abstract available
     
     
     August 2023
106. SKEI NV, Nilsen TIL, Mohus RM, Prescott HC, et al
     Trends in mortality after a sepsis hospitalization: a nationwide prospective registry study from 2008 to 2021.
     Infection. 2023 Aug 12. doi: 10.1007/s15010-023-02082.
     PubMed     Abstract available
     
     
     
107. HENTRICH M, Boll B, Teschner D, Panse J, et al
     Impact of the insertion site of central venous catheters on central venous catheter-related bloodstream infections in patients with cancer: results from a large prospective registry.
     Infection. 2023;51:1153-1159.
     PubMed     Abstract available
     
     
     
108. SEGALA FV, Pafundi PC, Masciocchi C, Fiori B, et al
     Incidence of bloodstream infections due to multidrug-resistant pathogens in ordinary wards and intensive care units before and during the COVID-19 pandemic: a real-life, retrospective observational study.
     Infection. 2023;51:1061-1069.
     PubMed     Abstract available
     
     
     
109. RENGGLI L, Gasser M, Buetti N, Kronenberg A, et al
     Increase in methicillin-susceptible Staphylococcus aureus bloodstream infections in Switzerland: a nationwide surveillance study (2008-2021).
     Infection. 2023;51:1025-1031.
     PubMed     Abstract available
     
     
     
110. ATAMNA A, Margalit I, Ayada G, Babich T, et al
     Outcomes of octogenarians and nonagenarians with Pseudomonas aeruginosa bacteremia: a multicenter retrospective study.
     Infection. 2023;51:1003-1012.
     PubMed     Abstract available
     
     
     June 2023
111. KIM SH, Jeon CH, Kim HT, Wi YM, et al
     Clinical characteristics and manifestations in patients with hypermucoviscous Klebsiella pneumoniae bacteremia from extra-hepatobiliary tract infection.
     Infection. 2023;51:689-696.
     PubMed     Abstract available
     
     
     
112. KOUIJZER IJE, Speijker LTD, Aarntzen EHJG, Rijnen WHC, et al
     Clinically unsuspected orthopedic implants during S. aureus bacteremia do not require additional diagnostic work-up.
     Infection. 2023;51:743-747.
     PubMed     Abstract available
     
     
     May 2023
113. TORVIK MA, Nymo SH, Nymo SH, Bjornsen LP, et al
     Correction: Patient characteristics in sepsis-related deaths: prevalence of advanced frailty, comorbidity, and age in a Norwegian hospital trust.
     Infection. 2023 May 12. doi: 10.1007/s15010-023-02046.
     PubMed    
     
     
     April 2023
114. REDA NM, Hassan RM, Salem ST, Yousef RHA, et al
     Prevalence and species distribution of Candida bloodstream infection in children and adults in two teaching university hospitals in Egypt: first report of Candida kefyr.
     Infection. 2023;51:389-395.
     PubMed     Abstract available
     
     
     
115. HACHISU Y, Tamura K, Murakami K, Fujita J, et al
     Invasive Haemophilus influenzae disease among adults in Japan during 2014-2018.
     Infection. 2023;51:355-364.
     PubMed     Abstract available
     
     
     March 2023
116. TORVIK MA, Nymo SH, Nymo SH, Bjornsen LP, et al
     Patient characteristics in sepsis-related deaths: prevalence of advanced frailty, comorbidity, and age in a Norwegian hospital trust.
     Infection. 2023 Mar 9. doi: 10.1007/s15010-023-02013.
     PubMed     Abstract available
     
     
     November 2022
117. LABORDE C, Deidda M, Bador J, Putot S, et al
     Apyrexia improves the prognostic value of quick SOFA in older patients with acute pneumonia or bacteremic urinary tract infection.
     Infection. 2022 Nov 29. doi: 10.1007/s15010-022-01953.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Sepsis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum